Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder
JAMA Network Open · 25.09.2024 · 7 (9) · e2435247
DOI: 10.1001/jamanetworkopen.2024.35247 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 25.09.2024. Verfasst von William Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Opiate Overdose, Opioid-Related Disorders. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIA NIH HHS.
Themen: Sucht und Abhängigkeit, Diabetes mellitus
Abstract (Originalsprache)
This cohort study uses emulation target trial methods to evaluate whether semaglutide is associated with lower rates of opioid overdose among patients with type 2 diabetes (T2D) and opioid use disorder (OUD).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio.
- National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
- Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
- Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.
- Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, Ohio.
- Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio.
Förderung
- NCATS NIH HHS
- NIA NIH HHS
Zitieren
APA
Wang, W., Volkow, N. D., Wang, Q., Berger, N. A., Davis, P. B., Kaelber, D. C., & Xu, R. (2024). Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder. JAMA Network Open, 7(9), e2435247. https://doi.org/10.1001/jamanetworkopen.2024.35247
Vancouver
Wang W, Volkow ND, Wang Q, Berger NA, Davis PB, Kaelber DC, et al. Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder. JAMA Network Open. 2024;7(9):e2435247. doi:10.1001/jamanetworkopen.2024.35247
BibTeX
@article{Wang2024,
author = {Wang, William and Volkow, Nora D and Wang, QuangQiu and Berger, Nathan A and Davis, Pamela B and Kaelber, David C and Xu, Rong},
title = {Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {9},
pages = {e2435247},
doi = {10.1001/jamanetworkopen.2024.35247}
}
EUVIMED